biOasis Technologies Inc - ESG Rating & Company Profile powered by AI
The page displays a zero-cost ESG analysis for biOasis Technologies Inc. This assessment of biOasis Technologies Inc leverages data from across the internet and also from available disclosures by biOasis Technologies Inc. The ESG rating for biOasis Technologies Inc represents its reporting of the UN SDGs.
biOasis Technologies Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.1; made up of an environmental score of 4.0, social score of 2.7 and governance score of 2.7.
3.1
Low ImpactEnvironmental
Social
Governance

Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1299 | Active Fine Chemicals Ltd | 3.2 | Medium |
1299 | Yuhan Corp | 3.2 | Medium |
1309 | biOasis Technologies Inc | 3.1 | Medium |
1309 | Champions Oncology Inc | 3.1 | Medium |
1309 | IBEX Technologies Inc | 3.1 | Medium |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |

Frequently Asked Questions
Does biOasis Technologies Inc have an accelerator or VC vehicle to help deliver innovation?
Does biOasis Technologies Inc disclose current and historical energy intensity?
Does biOasis Technologies Inc report the average age of the workforce?
Does biOasis Technologies Inc reference operational or capital allocation in relation to climate change?
Does biOasis Technologies Inc disclose its ethnicity pay gap?
Does biOasis Technologies Inc disclose cybersecurity risks?
Does biOasis Technologies Inc offer flexible work?
Does biOasis Technologies Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does biOasis Technologies Inc disclose the number of employees in R&D functions?
Does biOasis Technologies Inc conduct supply chain audits?
Does biOasis Technologies Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does biOasis Technologies Inc conduct 360 degree staff reviews?
Does biOasis Technologies Inc disclose the individual responsible for D&I?
Does biOasis Technologies Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does biOasis Technologies Inc disclose current and / or historical scope 2 emissions?
Does biOasis Technologies Inc disclose water use targets?
Does biOasis Technologies Inc have careers partnerships with academic institutions?
Did biOasis Technologies Inc have a product recall in the last two years?
Does biOasis Technologies Inc disclose incidents of discrimination?
Does biOasis Technologies Inc allow for Work Councils/Collective Agreements to be formed?
Has biOasis Technologies Inc issued a profit warning in the past 24 months?
Does biOasis Technologies Inc disclose parental leave metrics?
Does biOasis Technologies Inc disclose climate scenario or pathway analysis?
Does biOasis Technologies Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does biOasis Technologies Inc disclose the pay ratio of women to men?
Does biOasis Technologies Inc support suppliers with sustainability related research and development?
Does biOasis Technologies Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does biOasis Technologies Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is biOasis Technologies Inc involved in embryonic stem cell research?
Does biOasis Technologies Inc disclose GHG and Air Emissions intensity?
Does biOasis Technologies Inc disclose its waste policy?
Does biOasis Technologies Inc report according to TCFD requirements?
Does biOasis Technologies Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does biOasis Technologies Inc disclose energy use targets?
Does biOasis Technologies Inc disclose its Renewable Energy targets?

Are emissions metrics verified by STBi?

Does biOasis Technologies Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for biOasis Technologies Inc
These potential risks are based on the size, segment and geographies of the company.
Bioasis Technologies Inc., a development stage biopharmaceutical company, engages in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. It is developing xB3, a platform technology for the delivery of therapeutics across the blood-brain barrier (BBB); and the treatment of central nervous system disorders, including brain cancers, and metabolic and neurodegenerative diseases. The company's in-house development programs develop symptomatic and disease-modifying treatments for brain metastases (xB3-001), glioblastoma (xB3-002), and neurodegenerative diseases (xB3-007). Bioasis Technologies Inc. has research collaborations with Aposense Limited to focus on the delivery of siRNA into the brain; and Oxyrane UK Ltd. to focus on combining xB3 technology and Oxyrane's OxyCAT platform to deliver an undisclosed enhanced enzyme replacement therapy into the brain. The company was incorporated in 2006 and is headquartered in New Haven, Connecticut.